retatrutide glp-1 gip glucagon agonist Retatrutide, a GIP, and receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA Triple GLP-1 / GIP /

Nausea after eating is a common side effect of semaglutide and other GLP-1 medications, affecting up to 40% of users in clinical trials

Understanding how these compounds interact with your body's fluid balance and renal health is essential for safe, effective treatment

At present, GLP-1RAs have become highly effective treatments for managing type 2 diabetes mellitus and obesity

Understanding what to expect helps you stay committed to your weight loss journey

Get personalized weight loss & hormone therapy at Simply Thrive Medical

The common side effects reported are similar to GLP-1 agonists, and include nausea, vomiting, diarrhea, abdominal discomfort, bloating, and constipation